{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:30:45Z","timestamp":1792373445979,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS095563"],"award-info":[{"award-number":["R01 NS095563"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["09\/01\/2015 to 08\/31\/2020"],"award-info":[{"award-number":["09\/01\/2015 to 08\/31\/2020"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008900","name":"University of South Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007919","name":"University of Massachusetts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nano.2019.102119","type":"journal-article","created":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T10:12:34Z","timestamp":1572171154000},"page":"102119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration"],"prefix":"10.1016","volume":"24","author":[{"given":"Vasyl","family":"Sava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Fihurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Khvorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sanchez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nano.2019.102119_bb0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.nano.2019.102119_bb0010","first-page":"971","article-title":"The Huntington's disease collaborative research group","volume":"72","author":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.nano.2019.102119_bb0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington's disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J"},{"key":"10.1016\/j.nano.2019.102119_bb0020","series-title":"Landwehrmeyer GB","author":"Tabrizi","year":"2019"},{"issue":"6","key":"10.1016\/j.nano.2019.102119_bb0025","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","article-title":"Mouse models of Huntington's disease and methodological considerations for therapeutic trials","volume":"1792","author":"Ferrante","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2019.102119_bb0030","first-page":"4","article-title":"Hydrophobically modified siRNAs silence Huntingtin mRNA in primary neurons and mouse brain","volume":"e266","author":"Alterman","year":"2015","journal-title":"Molecular therapy Nucleic acids"},{"issue":"5","key":"10.1016\/j.nano.2019.102119_bb0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington's disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.nano.2019.102119_bb0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jddst.2017.11.013","article-title":"Chitosan-mangafodipir nanoparticles designed for intranasal delivery of siRNA and DNA to brain","volume":"43","author":"Sanchez-Ramos","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.nano.2019.102119_bb0045","unstructured":"Sanchez-Ramos J, Sava V, Song S, Mohapatra S, Mohapatra S, Inventors. Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation. 2013."},{"key":"10.1016\/j.nano.2019.102119_bb0050","unstructured":"Fihurka O, Sanchez-Ramos J, Sava V. Optimizing nanoparticle design for gene therapy: protection of oligonucleotides from degradation without impeding release of cargo. Nanomed Nanosci Res. 2018;2(6)."},{"issue":"12","key":"10.1016\/j.nano.2019.102119_bb0055","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1128\/iai.63.12.4770-4773.1995","article-title":"Chitinase activity in human serum and leukocytes","volume":"63","author":"Escott","year":"1995","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.nano.2019.102119_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10731199009117286","article-title":"Chitosan\u2014as a biomaterial","volume":"18","author":"Chandy","year":"1990","journal-title":"Biomater Artif Cells Artif Organs"},{"issue":"4","key":"10.1016\/j.nano.2019.102119_bb0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ymthe.2006.04.010","article-title":"RNA interference in vitro and in vivo using a novel chitosan\/siRNA nanoparticle system","volume":"14","author":"Howard","year":"2006","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.nano.2019.102119_bb0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","article-title":"Physical and chemical stability of drug nanoparticles","volume":"63","author":"Wu","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.nano.2019.102119_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","article-title":"Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products","volume":"364","author":"Van Eerdenbrugh","year":"2008","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2019.102119_bb0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejpb.2008.01.025","article-title":"How to concentrate nanoparticles and avoid aggregation?","volume":"69","author":"Vauthier","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"10.1016\/j.nano.2019.102119_bb0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jlcr.3292","article-title":"Enhancing radiolytic stability upon concentration of tritium-labeled pharmaceuticals utilizing centrifugal evaporation","volume":"58","author":"Marques","year":"2015","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.nano.2019.102119_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/srep12166","article-title":"Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression","volume":"5","author":"Southwell","year":"2015","journal-title":"Sci Rep"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419302035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419302035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:32:27Z","timestamp":1778617947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963419302035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":18,"alternative-id":["S1549963419302035"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2019.102119","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2019.102119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102119"}}